These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Short-term and sustained renal effects of angiotensin II receptor blockade in healthy subjects. Burnier M; Hagman M; Nussberger J; Biollaz J; Armagnac C; Brouard R; Weber B; Brunner HR Hypertension; 1995 Apr; 25(4 Pt 1):602-9. PubMed ID: 7721404 [TBL] [Abstract][Full Text] [Related]
5. Angiotensin II enhances insulin sensitivity in healthy volunteers under euglycemic conditions. Fliser D; Arnold U; Kohl B; Hartung R; Ritz E J Hypertens; 1993 Sep; 11(9):983-8. PubMed ID: 8254181 [TBL] [Abstract][Full Text] [Related]
6. AT-1 receptor antagonism modifies the mediation of endothelin-1, thromboxane A2, and catecholamines in the renal constrictor response to angiotensin II. Cediel E; de Las Heras N; Sanz-Rosa D; Velasco O; Cachofeiro V; Lahera V Kidney Int Suppl; 2005 Jan; (93):S3-9. PubMed ID: 15613065 [TBL] [Abstract][Full Text] [Related]
7. Effect of angiotensin II on pulse wave velocity in humans is mediated through angiotensin II type 1 (AT(1)) receptors. Rehman A; Rahman AR; Rasool AH J Hum Hypertens; 2002 Apr; 16(4):261-6. PubMed ID: 11967720 [TBL] [Abstract][Full Text] [Related]
8. Angiotensin II receptor blockade in normotensive subjects: A direct comparison of three AT1 receptor antagonists. Mazzolai L; Maillard M; Rossat J; Nussberger J; Brunner HR; Burnier M Hypertension; 1999 Mar; 33(3):850-5. PubMed ID: 10082498 [TBL] [Abstract][Full Text] [Related]
9. Hyperglycemia and angiotensin-mediated control of the renal circulation in healthy humans. Osei SY; Price DA; Fisher ND; Porter L; Laffel LM; Hollenberg NK Hypertension; 1999 Jan; 33(1 Pt 2):559-64. PubMed ID: 9931165 [TBL] [Abstract][Full Text] [Related]
10. Endothelin ETA receptor-subtype specific antagonism does not mitigate the acute systemic or renal effects of exogenous angiotensin II in humans. Bayerle-Eder M; Langenberger H; Pleiner J; Polska E; Mensik C; Eichler HG; Wolzt M; Schmetterer L Eur J Clin Invest; 2002 Apr; 32(4):230-5. PubMed ID: 11952807 [TBL] [Abstract][Full Text] [Related]
11. Failure of angiotensin II to suppress plasma renin activity in normotensive subjects with a positive family history of hypertension. Herlitz H; Palmgren E; Widgren B; Aurell M Clin Sci (Lond); 2005 Sep; 109(3):311-7. PubMed ID: 15901242 [TBL] [Abstract][Full Text] [Related]
12. Losartan blocks aldosterone and renal vascular responses to angiotensin II in humans. Gandhi SK; Ryder DH; Brown NJ Hypertension; 1996 Dec; 28(6):961-6. PubMed ID: 8952583 [TBL] [Abstract][Full Text] [Related]
13. Effect of intrarenal infusion of angiotensin-(1-7) in the dog. Heller J; Kramer HJ; Malý J; Cervenka L; Horácek V Kidney Blood Press Res; 2000; 23(2):89-94. PubMed ID: 10765110 [TBL] [Abstract][Full Text] [Related]
14. Functional role of angiotensin II type 1 and 2 receptors in regulation of uterine blood flow in nonpregnant sheep. Lambers DS; Greenberg SG; Clark KE Am J Physiol Heart Circ Physiol; 2000 Feb; 278(2):H353-9. PubMed ID: 10666064 [TBL] [Abstract][Full Text] [Related]
15. Effects of losartan on vasoconstrictor responses to angiotensin II in the forearm vascular bed of healthy volunteers. Baan J; Chang PC; Vermeij P; Pfaffendorf M; van Zwieten PA Cardiovasc Res; 1996 Nov; 32(5):973-9. PubMed ID: 8944829 [TBL] [Abstract][Full Text] [Related]
17. Angiotensin II affects basal, pulsatile, and glucose-stimulated insulin secretion in humans. Fliser D; Schaefer F; Schmid D; Veldhuis JD; Ritz E Hypertension; 1997 Nov; 30(5):1156-61. PubMed ID: 9369270 [TBL] [Abstract][Full Text] [Related]
18. AT(2) receptor-mediated vasodilation in the heart: effect of myocardial infarction. Schuijt MP; Basdew M; van Veghel R; de Vries R; Saxena PR; Schoemaker RG; Danser AH Am J Physiol Heart Circ Physiol; 2001 Dec; 281(6):H2590-6. PubMed ID: 11709427 [TBL] [Abstract][Full Text] [Related]
19. Impact of gender on the renal response to angiotensin II. Miller JA; Anacta LA; Cattran DC Kidney Int; 1999 Jan; 55(1):278-85. PubMed ID: 9893137 [TBL] [Abstract][Full Text] [Related]
20. Comparison of angiotensin-converting enzyme inhibition with angiotensin II receptor antagonism in the human forearm. Cockcroft JR; Sciberras DG; Goldberg MR; Ritter JM J Cardiovasc Pharmacol; 1993 Oct; 22(4):579-84. PubMed ID: 7505360 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]